These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36043665)

  • 61. Updates in deep learning research in ophthalmology.
    Ng WY; Zhang S; Wang Z; Ong CJT; Gunasekeran DV; Lim GYS; Zheng F; Tan SCY; Tan GSW; Rim TH; Schmetterer L; Ting DSW
    Clin Sci (Lond); 2021 Oct; 135(20):2357-2376. PubMed ID: 34661658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diving Deep into Deep Learning: An Update on Artificial Intelligence in Retina.
    Goldhagen BE; Al-Khersan H
    Curr Ophthalmol Rep; 2020 Sep; 8(3):121-128. PubMed ID: 33224635
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diabetic Eye Disease: Advancements in Technology, Detection, and Access to Care.
    Lyford T; Sheppard J
    Sr Care Pharm; 2020 Jun; 35(6):266-272. PubMed ID: 32456756
    [No Abstract]   [Full Text] [Related]  

  • 64. ARTEFICIAL INTELLIGENCE IN DIABETIC RETINOPATHY SCREENING. A REVIEW.
    Straňák Z; Penčák M; Veith M
    Cesk Slov Oftalmol; 2021; 77(5):224-231. PubMed ID: 34666491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The American Society of Retina Specialists Artificial Intelligence Task Force Report.
    Talcott KE; Kim JE; Modi Y; Moshfeghi DM; Singh RP
    J Vitreoretin Dis; 2020; 4(4):312-319. PubMed ID: 37009187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application.
    Bellemo V; Lim G; Rim TH; Tan GSW; Cheung CY; Sadda S; He MG; Tufail A; Lee ML; Hsu W; Ting DSW
    Curr Diab Rep; 2019 Jul; 19(9):72. PubMed ID: 31367962
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can Artificial Intelligence Make Screening Faster, More Accurate, and More Accessible?
    Li Z; Keel S; Liu C; He M
    Asia Pac J Ophthalmol (Phila); 2018; 7(6):436-441. PubMed ID: 30556381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Application of artificial intelligence-based dual-modality analysis combining fundus photography and optical coherence tomography in diabetic retinopathy screening in a community hospital.
    Liu R; Li Q; Xu F; Wang S; He J; Cao Y; Shi F; Chen X; Chen J
    Biomed Eng Online; 2022 Jul; 21(1):47. PubMed ID: 35859144
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tracking Online Interest in Artificial Intelligence in Ophthalmology Using Google Trends.
    Ahuja AS; Rahimy E; Sridhar J
    Semin Ophthalmol; 2023 Oct; 38(7):644-647. PubMed ID: 37095683
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology.
    Veritti D; Rubinato L; Sarao V; De Nardin A; Foresti GL; Lanzetta P
    Graefes Arch Clin Exp Ophthalmol; 2024 Mar; 262(3):975-982. PubMed ID: 37747539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition.
    Horton MB; Brady CJ; Cavallerano J; Abramoff M; Barker G; Chiang MF; Crockett CH; Garg S; Karth P; Liu Y; Newman CD; Rathi S; Sheth V; Silva P; Stebbins K; Zimmer-Galler I
    Telemed J E Health; 2020 Apr; 26(4):495-543. PubMed ID: 32209018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glaucoma management in the era of artificial intelligence.
    Devalla SK; Liang Z; Pham TH; Boote C; Strouthidis NG; Thiery AH; Girard MJA
    Br J Ophthalmol; 2020 Mar; 104(3):301-311. PubMed ID: 31640973
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Need for Artificial Intelligence Based Risk Factor Analysis for Age-Related Macular Degeneration: A Review.
    Vyas A; Raman S; Surya J; Sen S; Raman R
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.
    Pashkov VM; Harkusha AO; Harkusha YO
    Wiad Lek; 2020; 73(12 cz 2):2722-2727. PubMed ID: 33611272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Research progress on diagnosing retinal vascular diseases based on artificial intelligence and fundus images.
    Ji Y; Ji Y; Liu Y; Zhao Y; Zhang L
    Front Cell Dev Biol; 2023; 11():1168327. PubMed ID: 37056999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Latest developments of generative artificial intelligence and applications in ophthalmology.
    Feng X; Xu K; Luo MJ; Chen H; Yang Y; He Q; Song C; Li R; Wu Y; Wang H; Tham YC; Ting DSW; Lin H; Wong TY; Lam DS
    Asia Pac J Ophthalmol (Phila); 2024; 13(4):100090. PubMed ID: 39128549
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Not Available].
    Grauslund J; Vorum H
    Ugeskr Laeger; 2023 Nov; 185(48):. PubMed ID: 38018727
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.